Skip to content

Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation

Analysis of Events of Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04394429
Acronym
TubeObs-Covid
Enrollment
184
Registered
2020-05-19
Start date
2020-04-24
Completion date
2021-06-24
Last updated
2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sars-CoV2

Keywords

Endotracheal Tube, ETT, Intubation, Mechanical ventilation, Endotracheal tube obstruction, ICU, Covid-19, SARS-CoV-2, ARDS

Brief summary

The COVID-19 pandemic is very present in our region, the Grand-Est region is considered as one of the first COVID-19 epicentres in France. COVID-19 causes an acute respiratory distress syndrome requiring prolonged mechanical ventilation in resuscitation.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Major Subject (≥18 years) * Subject with COVID 19 (radiological suspicion or microbiological confirmation) * Subject hospitalised in the intensive care unit at the NHC of the University Hospitals of Strasbourg between 01/03/2020 and 03/04/2020. * Subject treated by mechanical ventilation * Subject who has not expressed his opposition, after information, to the re-use of his data for the purposes of this research Translated with www.DeepL.com/Translator (free version)

Exclusion criteria

* Subject who expressed opposition to participating in the study * Subject under guardianship, curatorship or safeguarding of justice

Design outcomes

Primary

MeasureTime frame
Analysis of risk factors for intubation tube obstruction1 month

Countries

France

Contacts

Primary ContactBob HEGER, MD
Bob.Heger@chru-strasbourg.fr33 3.69.55.04.43
Backup ContactSaïd CHAYER, PhD, HDR
said.chayer@chru-strasbourg.fr33 3 88 11 66 90

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026